We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Trial Details
Key Eligibility Criteria
153 Participants Needed
Trial Details
Key Eligibility Criteria
1092 Participants Needed
Trial Details
Key Eligibility Criteria
2310 Participants Needed
Trial Details
Key Eligibility Criteria
93 Participants Needed
Trial Details
Key Eligibility Criteria
8100 Participants Needed
Trial Details
Key Eligibility Criteria
20 Participants Needed
Trial Details
Key Eligibility Criteria
265 Participants Needed
Trial Details
Key Eligibility Criteria
18 Participants Needed
Trial Details
Key Eligibility Criteria
422 Participants Needed
Trial Details
Key Eligibility Criteria
1097 Participants Needed
Trial Details
Key Eligibility Criteria
189 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
216 Participants Needed
Trial Details
Key Eligibility Criteria
38 Participants Needed
Trial Details
Key Eligibility Criteria
592 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
400 Participants Needed
Trial Details
Key Eligibility Criteria
40 Participants Needed
Trial Details
Key Eligibility Criteria
130 Participants Needed
Trial Details
Key Eligibility Criteria
474 Participants Needed
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
Trial Details
Key Eligibility Criteria
332 Participants Needed
Trial Details
Key Eligibility Criteria
849 Participants Needed
Trial Details
Key Eligibility Criteria
2005 Participants Needed
Trial Details
Key Eligibility Criteria
400 Participants Needed
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Trial Details
Key Eligibility Criteria
915 Participants Needed
Trial Details
Key Eligibility Criteria
365 Participants Needed
Trial Details
Key Eligibility Criteria
915 Participants Needed
Trial Details
Key Eligibility Criteria
1564 Participants Needed
Trial Details
Key Eligibility Criteria
800 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Acth trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Acth is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Osilodrostat for Autonomous Cortisol Secretion, CRH Stimulation for Cushing's Disease and Osilodrostat for Autonomous Cortisol Secretion to the Power online platform.